Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
NextEra Energy
NEE
$188B
| $58.1M | 0.02% |
792,606
-700,938
| -47% | -$52.6M |
|
527
Insight Enterprises
NSIT
$3.78B
| $58.1M | 0.02% |
580,601
-87,913
| -13% | -$8.89M |
|
528
Assurant
AIZ
$13.9B
| $58M | 0.02% |
371,576
-13,467
| -3% | -$2.1M |
|
529
Valero Energy
VLO
$88.8B
| $58M | 0.02% |
742,937
+206,616
| +39% | +$16M |
|
530
Philip Morris
PM
$317B
| $58M | 0.02% |
585,290
+226,234
| +63% | +$21.7M |
|
531
Vanguard Small-Cap ETF
VB
$80.2B
| $57.9M | 0.02% |
256,860
-21,578
| -8% | -$4.78M |
|
|
EPIX
532
DELISTED
ESSA Pharma
EPIX
| $57.7M | 0.02% |
2,017,894
+501,792
| +33% | +$14.6M |
|
533
QuantumScape Corp
QS
$3.14B
| $57M | 0.02% |
1,948,287
+927
| +0% | +$30K |
|
534
Travere Therapeutics
TVTX
$5.16B
| $57M | 0.02% |
3,905,113
-245,443
| -6% | -$4.84M |
|
535
News Corp Class A
NWSA
$15.3B
| $57M | 0.02% |
2,210,383
+732,840
| +50% | +$19.3M |
|
536
Bath & Body Works
BBWI
$4.18B
| $56.9M | 0.02% |
+976,122
| New | +$52.7M |
|
537
Vontier
VNT
$4.62B
| $56.6M | 0.02% |
1,738,303
+191,026
| +12% | +$6.29M |
|
538
Criteo
CRTO
$1.05B
| $56.5M | 0.02% |
1,250,204
-239,799
| -16% | -$9.24M |
|
|
FITB
539
Fifth Third Bancorp
FITB
$52B
| $56.3M | 0.02% |
1,472,029
-168,492
| -10% | -$6.74M |
|
|
BCYC
540
Bicycle Therapeutics
BCYC
$274M
| $56.2M | 0.02% |
1,849,720
+156,062
| +9% | +$4.72M |
|
541
Colgate-Palmolive
CL
$75.1B
| $55.9M | 0.02% |
687,514
-241,819
| -26% | -$19.8M |
|
542
Grocery Outlet
GO
$934M
| $55.4M | 0.02% |
+1,599,693
| New | +$58.5M |
|
543
National Health Investors
NHI
$3.81B
| $55.2M | 0.02% |
823,745
+222,091
| +37% | +$15.5M |
|
544
Agilon Health
AGL
$1.63B
| $55M | 0.02% |
+54,269
| New | +$47.5M |
|
545
DuPont de Nemours
DD
$19.1B
| $55M | 0.02% |
565,858
+39,180
| +7% | +$3.93M |
|
|
CSW
546
CSW Industrials
CSW
$4.86B
| $55M | 0.02% |
464,011
-14,805
| -3% | -$1.89M |
|
547
Rocket Pharmaceuticals
RCKT
$344M
| $54.7M | 0.02% |
1,235,489
-5,827
| -0.5% | -$253K |
|
548
Allstate
ALL
$69.5B
| $54.7M | 0.02% |
419,187
+26,548
| +7% | +$3.43M |
|
549
Healthcare Services Group
HCSG
$1.58B
| $54.6M | 0.02% |
1,729,306
+151,959
| +10% | +$4.62M |
|
550
Praxis Precision Medicines
PRAX
$8.24B
| $54.4M | 0.02% |
198,566
+127,673
| +180% | +$45.7M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.